中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

土三七水煎剂所致肝小静脉闭塞病大鼠模型的建立

宋宇 禹铮 樊艳华 姚树坤 王泰龄

引用本文:
Citation:

土三七水煎剂所致肝小静脉闭塞病大鼠模型的建立

详细信息
  • 中图分类号: R-332;R595.3

A rat model of hepatic veno-occlusive disease induced by the Gynura root water decoction

  • 摘要: 目的通过观察不同浓度土三七水煎剂所致的大鼠肝脏病理学变化,建立一种模拟临床患者服药所致肝小静脉闭塞病(HVOD)的动物模型。方法土三七2100 g水煎制成浓度为1.5 g/ml土三七生药煎剂,SD大鼠76只随机分为A、B、C、D四组,A、B、C组每组20只,分别以土三七水煎剂高(15 g.kg-1.d-1)、中(7.5 g.kg-1.d-1)、低(3.75 g.kg-1.d-1)浓度灌胃,D组16只以温开水灌胃作为对照,各组大鼠雌、雄各半。每日测量大鼠体重并记录异常表现,灌胃1周和2周后各组大鼠分别处死各半,肝脏标本行病理检查,HE及Masson染色,光镜下参照Deleve评分标准判定病变及严重程度。结果土三七高、中、低浓度组分别有83.3%(15/18)、75.0%(15/20)、40.0%(5/20)出现了肝小静脉闭塞病病理表现;相同剂量下雌性较雄性更易发病,雌、雄鼠造模成功率分别为79.3%(23/29)和41.3%(12/29)(P=0.003)。结论土三七水煎剂灌胃可以成功建立HVOD大鼠模型,剂量和大鼠性别与造模成功率直接相关。

     

  • [1]宋宇, 樊艳华.土三七所致肝小静脉闭塞病102例临床分析[J].临床肝胆病杂志, 2011, 27 (5) :496-499.
    [2]DeLeve LD, Mccuskey RS, Wang X, et al.Characterization of aReproducible Rat Model of Hepatic Veno-occlusive Disease[J].Hepatology, 1999, 29 (6) :1779-1791.
    [3]冀涛.MMP-9在土三七致肝窦阻塞综合征中的表达及意义[D].浙江:浙江大学, 2009.
    [4]高新生, 肖绍树, 贺降福.土三七生物碱成分分析及肝小静脉闭塞病小鼠模型建立[J].中国中西医结合消化杂志, 2006, 14 (5) :311-313.
    [5]Kaikita K, Fogo AB, Ma L, et al.Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in re-sponse to long-term nitric oxide synthase inhibition[J].Circula-tion, 2001, 104 (7) :839-844.
    [6]Smith LH, Dixon JD, Stringham JR, et al.Pivotal role of PAI-1in a murine model of hepatic vein thrombosis[J].Blood, 2006, 107 (1) :132-134.
    [7]Czauderna P, Chyczewski L, Lech K, et al.Experimental model of he-patic venoocclusive disease (VOD) caused by dactinomycin--pre-liminary report about hepatoprotective effect of amifostine[J].Med SciMonit, 2000, 6 (3) :446-453.
    [8]Epstein RB, Min KW, Anderson SL, et al.A canine model for he-patic venoocclusive disease[J].Transplantation, 1992, 54 (1) :12-16.
    [9]Miranda CL, Reed RL, Guengerich FP, et al.Role of cytochromeP450IIIA4 in the metabolism of the pyrrolizidine alkaloid sene-cionine in human liver[J].Carcinogenesis, 1991, 12 (3) :515-519.
    [10]Meibohm B, Beierle I, Derendorf H.How important are genderdifferences in pharmacokinetics[J].Clin Pharmacokinet, 2002, 41 (5) :329-342.
    [11]Yu AM, Fukamachi K, Krausz KW, et al.Potential Role for Hu-man Cytochrome P450 3A4 in Estradiol Homeostasis[J].Endocri-nology, 2005, 146 (7) :2911-2919.
    [12]Deleve LD, Wang X, Tsai J, et a1.Sinusoidal obstruction syn-drome (veno-occlusive disease) in the rat is prevented by matrixmetalloproteinase inhibition[J].Gastroenterology, 2003, 125 (3) :882-890.
    [13]Hoetzer GL, Maceneaney OJ, Irmiger HM, et al.Gender differencein circulating endothelial progenitor cell colony-forming capacityand migratory activity in middle-aged adults[J].Am J Cardiol, 2007, 99 (1) :46-48
    [14]Strehlow K, Werner N, Berweiler J, et al.Estrogen increases bonemarrow derived endothelial progenitor cell production and diminishesneointima formation[J].Circulation, 2003, 107 (24) :3059-3065.
    [15]Heissig B, Hattori K, Dias S, et al.Recruitment of stem cell andprogenitor cells from the bone marrow niche requires MMP-9 medi-ated release of Kit-ligand[J].Cell, 2002, 109 (5) :625-637.
  • 加载中
计量
  • 文章访问数:  3254
  • HTML全文浏览量:  15
  • PDF下载量:  1133
  • 被引次数: 0
出版历程
  • 出版日期:  2011-08-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回